S. Semary, Hanaa M. Rashad, Sonya Soliman, N. Elsharkawy, Naglaa Elkinaai, Eman Nageb, Iman Zaky, A. Elnashar, A. Hamoda
{"title":"埃及儿童癌症医院复发小儿淋巴细胞淋巴瘤的预后因素、治疗方法和结果","authors":"S. Semary, Hanaa M. Rashad, Sonya Soliman, N. Elsharkawy, Naglaa Elkinaai, Eman Nageb, Iman Zaky, A. Elnashar, A. Hamoda","doi":"10.21608/jcbr.2023.249962.1321","DOIUrl":null,"url":null,"abstract":"Background : Pediatric patients with relapsed lymphoblastic lymphoma (LBL) have poor prognoses. Aim: This study aims to evaluate the prognostic factors, chemotherapy used, the role of hematopoietic stem cell transplantation (HSCT)","PeriodicalId":506427,"journal":{"name":"International Journal of Cancer and Biomedical Research","volume":"17 4","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Prognostic factors, lines of treatment, and outcome of relapsed pediatric lymphoblastic lymphoma in Children Cancer Hospital Egypt\",\"authors\":\"S. Semary, Hanaa M. Rashad, Sonya Soliman, N. Elsharkawy, Naglaa Elkinaai, Eman Nageb, Iman Zaky, A. Elnashar, A. Hamoda\",\"doi\":\"10.21608/jcbr.2023.249962.1321\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Background : Pediatric patients with relapsed lymphoblastic lymphoma (LBL) have poor prognoses. Aim: This study aims to evaluate the prognostic factors, chemotherapy used, the role of hematopoietic stem cell transplantation (HSCT)\",\"PeriodicalId\":506427,\"journal\":{\"name\":\"International Journal of Cancer and Biomedical Research\",\"volume\":\"17 4\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Cancer and Biomedical Research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.21608/jcbr.2023.249962.1321\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Cancer and Biomedical Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21608/jcbr.2023.249962.1321","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Prognostic factors, lines of treatment, and outcome of relapsed pediatric lymphoblastic lymphoma in Children Cancer Hospital Egypt
Background : Pediatric patients with relapsed lymphoblastic lymphoma (LBL) have poor prognoses. Aim: This study aims to evaluate the prognostic factors, chemotherapy used, the role of hematopoietic stem cell transplantation (HSCT)
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
